|
|
||||||||
1From the National Creutzfeldt-Jakob Disease Surveillance Unit and Department of Pathology of the University of Edinburgh, Scotland, United Kingdom; and the 2Academic Department of Ophthalmology, Manchester Royal Eye Hospital, Manchester, United Kingdom.
PURPOSE. Creutzfeldt-Jakob disease (CJD) primarily affects the brain. This study was conducted to assess the possible involvement of the eye in sporadic and variant CJD by testing for the presence of the disease-associated, protease-resistant isoform of the prion protein (PrPSc) in ocular tissue.
METHODS. Human eyes from donors with CJD and non-prion neurodegenerative disease control eyes were studied. In situ hybridization and Western blot analysis were used to determine the normal pattern of cellular prion protein (PrPC) expression. Western blot analysis and immunohistochemistry were then used to determine the localization, abundance, and isotype of PrPSc in eyes in CJD.
RESULTS. PrPC was expressed in the nuclear layers of the retina. In both the sporadic and variant forms of CJD, PrPSc accumulated throughout the synaptic layers of the retina. The levels of PrPSc found in the retina were comparable with those found in the brain. Lower levels of PrPSc could be found in the optic nerve, but no PrPSc was detectable in other ocular tissues. The glycoform ratio of PrPSc in the retina did not correspond to that found in the brain.
CONCLUSIONS. Presumptive centrifugal spread of PrPSc from the brain through the optic nerve occurs in two major types of CJD. PrPSc is a marker of CJD infectivity. Given that routine decontamination may not remove PrPSc from surgical instruments, a careful risk assessment should be made of possible iatrogenic spread of sporadic and variant CJD after surgery to the retina or optic nerve.
This article has been cited by other articles:
![]() |
J. Gong, A. Jellali, V. Forster, J. Mutterer, E. Dubus, W. D. Altrock, J. A. Sahel, A. Rendon, and S. Picaud The Toxicity of the PrP106-126 Prion Peptide on Cultured Photoreceptors Correlates with the Prion Protein Distribution in the Mammalian and Human Retina Am. J. Pathol., April 1, 2007; 170(4): 1314 - 1324. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Peden, D. L. Ritchie, H. P. Uddin, A. F. Dean, K. A. F. Schiller, M. W. Head, and J. W. Ironside Abnormal prion protein in the pituitary in sporadic and variant Creutzfeldt-Jakob disease J. Gen. Virol., March 1, 2007; 88(3): 1068 - 1072. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Greenlee, A. N. Hamir, and M. H. West Greenlee Abnormal prion accumulation associated with retinal pathology in experimentally inoculated scrapie-affected sheep. Vet. Pathol., September 1, 2006; 43(5): 733 - 739. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. DeJoia, B. Moreaux, K. O'Connell, and R. A. Bessen Prion Infection of Oral and Nasal Mucosa J. Virol., May 1, 2006; 80(9): 4546 - 4556. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Herzog, J. Riviere, N. Lescoutra-Etchegaray, A. Charbonnier, V. Leblanc, N. Sales, J.-P. Deslys, and C. I. Lasmezas PrPTSE Distribution in a Primate Model of Variant, Sporadic, and Iatrogenic Creutzfeldt-Jakob Disease J. Virol., November 15, 2005; 79(22): 14339 - 14345. [Abstract] [Full Text] [PDF] |
||||
![]() |
S A Cooper, K L Murray, C A Heath, R G Will, and R S G Knight Isolated visual symptoms at onset in sporadic Creutzfeldt-Jakob disease: the clinical phenotype of the "Heidenhain variant" Br. J. Ophthalmol., October 1, 2005; 89(10): 1341 - 1342. [Abstract] [Full Text] [PDF] |
||||
![]() |
M W Head, A H Peden, H M Yull, D L Ritchie, R E Bonshek, A B Tullo, and J W Ironside Abnormal prion protein in the retina of the most commonly occurring subtype of sporadic Creutzfeldt-Jakob disease Br. J. Ophthalmol., September 1, 2005; 89(9): 1131 - 1138. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Castilla, A. Brun, F. Diaz-San Segundo, F. J. Salguero, A. Gutierrez-Adan, B. Pintado, M. A. Ramirez, L. del Riego, and J. M. Torres Vertical Transmission of Bovine Spongiform Encephalopathy Prions Evaluated in a Transgenic Mouse Model J. Virol., July 1, 2005; 79(13): 8665 - 8668. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-L. Bergstrom, H. Cordes, N. Zsurger, P. M. H. Heegaard, H. Laursen, and J. Chabry Amidation and Structure Relaxation Abolish the Neurotoxicity of the Prion Peptide PrP106-126 in Vivo and in Vitro J. Biol. Chem., June 17, 2005; 280(24): 23114 - 23121. [Abstract] [Full Text] [PDF] |
||||
![]() |
J S Mehta, R J Osborne, and P A Bloom Variant CJD and tonometry Br. J. Ophthalmol., April 1, 2004; 88(4): 597 - 598. [Full Text] [PDF] |
||||
![]() |
M. W. Head, D. Ritchie, N. Smith, V. McLoughlin, W. Nailon, S. Samad, S. Masson, M. Bishop, L. McCardle, and J. W. Ironside Peripheral Tissue Involvement in Sporadic, Iatrogenic, and Variant Creutzfeldt-Jakob Disease: An Immunohistochemical, Quantitative, and Biochemical Study Am. J. Pathol., January 1, 2004; 164(1): 143 - 153. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |